semaglutide and eating disorders No matter how generally beneficial or safe a drug is, it can be misused. A study out today, for instance, shows that people with are taking GLP-1 medications like ( GLP-1 RAs in Eating Disorders:

[13] [14] Weight Loss and Metabolic Adaptation The concern about metabolic "damage" often stems from the well-documented phenomenon of adaptive thermogenesisthe body's natural reduction in energy expenditure that occurs with significant weight loss, regardless of the method used

Expert Continuity of Care Because Melissa manages every aspect of your program, you never have to explain your history to a new provider

I trust BioActive Products

Tirzepatide (sold as Mounjaro and Zepbound) is FDA approved and available now, while Retatrutide remains in Phase 3 trials with expected approval sometime between 2026 and 2027